Dopamine, cocaine and the development of cerebral cortical cytoarchitecture: A review of current concepts

Seminars in Cell and Developmental Biology

Volumn 20, Issue 4, 2009, Pages 395-402

  Bhide, Pradeep G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Animal model; Cocaine; Dopamine; GABA; Neurogenesis; Neuronal migration

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE RECEPTOR; MONOAMINE; NEUROTRANSMITTER;

BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN REGION; COGNITION; CYTOARCHITECTURE; NONHUMAN; PRENATAL EXPOSURE; REVIEW;

ANIMALIA;

EID: 67649267969     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.01.006     Document Type: Review

References (85)

1. Chasnoff I.J., Griffith D.R., MacGregor S., Dirkes K., and Burns K.A. Temporal patterns of cocaine use in pregnancy. Perinatal outcome. JAMA 261 12 (1989) 1741-1744
2. Chasnoff I.J., Lewis D.E., Griffith D.R., and Willey S. Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clin Chem 35 7 (1989) 1276-1278
3. Delaney-Black V., Covington C., Ostrea Jr. E., Romero A., Baker D., Tagle M.T., et al. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics 98 4 Pt 1 (1996) 735-740
4. Kosofsky B.E., and Wilkins A.S. A mouse model of transplacental cocaine exposure. Clinical implications for exposed infants and children. Ann NY Acad Sci 846 (1998) 248-261
5. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 4819 (1987) 1219-1223
6. Ritz M.C., Cone E.J., and Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46 9 (1990) 635-645
7. Meyer J.S., Shearman L.P., Collins L.M., and Maguire R.L. Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action. Psychopharmacology 112 4 (1993) 445-451
8. Akbari H.M., Kramer H.K., Whitaker-Azmitia P.M., Spear L.P., and Azmitia E.C. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res 572 (1992) 57-63
9. Wang X.-H., Levitt P., Grayson D.R., and Murphy E.H. Intrauterine cocaine exposure of rabbits: persistent elevation of GABA-immunoreactive neurons in anterior cingulate cortex but not visual cortex. Brain Res 689 (1995) 32-46
10. Levitt P., Harvey J.A., Friedman E., Simansky K., and Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci 20 (1997) 269-274
11. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., et al. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci 20 12 (2000) 4606-4614
12. Kosofsky B.E., Wilkins A.S., Gressens P., and Evrard P. Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J Child Neurol 9 (1994) 234-241
13. Mayes L.C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol 11 4 (1999) 685-714
14. Gressens P., Kosofsky B.E., and Evrard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci Lett 140 (1992) 113-116
15. Baraban S.C., Wenzel H.J., Castro P.A., and Schwartzkroin P.A. Hippocampal dysplasia in rats exposed to cocaine in utero. Brain Res Dev Brain Res 117 2 (1999) 213-217
16. Lidow M.S. Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse 21 (1995) 332-341
17. Lidow M.S. Consequences of prenatal cocaine exposure in nonhuman primates. Brain Res Dev Brain Res 147 1-2 (2003) 23-36
18. Lidow M.S., Trakht T., and Howard R.L. Cocaine-induced alterations in the density of monoaminergic receptors in the embryonic guinea pig cerebral wall. Synapse 32 3 (1999) 225-237
19. Levitt P., Barbe M.F., and Eagleson K.L. Patterning and specification of the cerebral cortex. Annu. Rev. Neurosci. 20 (1997) 1-24
20. Akbari H.M., and Azmitia E.C. Increased tyrosine hydroxylase immunoreactivity in the rat cortex following prenatal cocaine exposure. Dev Brain Res 66 (1992) 277-281
21. 1 dopamine receptor system. Ann NY Acad Sci 846 (1998) 238-247
22. Friedman E., Yadin E., and Wang H.Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience 70 (1996) 739-747
23. Ronnekleiv O.K., Fang Y., Choi W.S., and Chai L. Changes in the midbrain-rostral forebrain dopamine circuitry in the cocaine-exposed primate fetal brain. Ann NY Acad Sci 846 (1998) 165-181
24. Ronnekleiv O.K., and Naylor B.R. Chronic cocaine exposure in the fetal rhesus monkey: consequences for early development of dopamine neurons. J Neurosci 15 (1995) 7330-7343
25. Simansky K., and Kachelries W.J. Prenatal exposure to cocaine selectively disrupts motor responses to D-amphetamine in young and mature rabbits. Neuropharmacology 35 (1996) 71-78
26. Ohtani N., Goto T., Waeber C., and Bhide P.G. Dopamine modulates cell cycle in the lateral ganglionic eminence. J Neurosci 23 7 (2003) 2840-2850
27. Araki K.Y., Sims J.R., and Bhide P.G. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res 1156 2 (July) (2007) 31-45
28. Lloyd S.A., Wensley B., Faherty C.J., and Smeyne R.J. Regional differences in cortical dendrite morphology following in utero exposure to cocaine. Brain Res Dev Brain Res 147 1-2 (2003) 59-66
29. Stanwood G.D., Washington R.A., Shumsky J.S., and Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience 106 1 (2001) 5-14
30. Stanwood G.D., Washington R.A., and Levitt P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb Cortex 11 5 (2001) 430-440
31. Levitt P., and Rakic P. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Brain Res 256 1 (1982) 35-57
32. Puelles L., and Verney C. Early neuromeric distribution of tyrosine-hydroxylase-immunoreactive neurons in human embryos. J Comp Neurol 394 (1998) 283-308
33. Golden G.S. Prenatal development of the biogenic amine systems of the mouse brain. Dev Biol 33 (1973) 300-311
34. Popolo M., McCarthy D.M., and Bhide P.G. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev Neurosci 26 (2004) 229-244
35. Monsma F.J., Mahan L.C., McVittie L.D., Gerfen C.R., and Sibley D.R. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 87 (1990) 6723-6727
36. Schinelli S., Paolillo M., and Corona G.L. Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J Neurochem 62 (1994) 944-949
37. Robinson S.W., and Caron M.G. Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEk 293 cells. J Neurochem 67 (1996) 212-219
38. Sibley D.R., and Monsma Jr. F.J. Molecular biology of dopamine receptors. Trends Pharmacol Sci 13 2 (1992) 61-69
39. Jin L.Q., Goswami S., Cai G., Zhen X., and Friedman E. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 85 2 (2003) 378-386
40. Rashid A.J., So C.H., Kong M.M., Furtak T., El-Ghundi M., Cheng R., et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104 2 (2007) 654-659
41. Jung A.B., and Bennett Jr. J.P. Development of striatal dopaminergic function. 1. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Dev Brain Res 94 (1996) 109-120
42. Schambra U.B., Duncan G.E., Breese G.R., Fornaretto M.G., Caron M.G., and Fremeau Jr. R.T. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62 (1994) 65-85
43. 125I]iodosulpiride. Neuroscience 28 (1989) 673-700
44. Lidow M.S., and Rakic P. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2 5 (1992) 401-416
45. 2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study. Dev Brain Res 60 (1993) 79-87
46. Gurevich E.V., and Joyce J.N. Dopamine D(3) receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat. J Comp Neurol 420 1 (2000) 35-51
47. Seeman P., Bzowej N.H., Guan H.C., Bergeron C., Becker L.E., Reynolds G.P., et al. Human brain dopamine receptors in children and aging adults. Synapse 1 5 (1987) 399-404
48. Shearman L.P., Zeitzer J., and Weaver D.R. Widespread expression of functional D1-dopamine receptors in fetal rat brain. Dev Brain Res 102 1 (1997) 105-115
49. Rao P.A., Molinoff P.B., and Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res 60 2 (1991) 161-177
50. McCarthy D., Lueras P., and Bhide P.G. Elevated dopamine levels during gestation produce region-specific decreases in neurogenesis and subtle deficits in neuronal numbers. Brain Res 1182 (2007) 11-25
51. Zhang L., and Lidow M.S. D1 dopamine receptor regulation of cell cycle in FGF- and EGF-supported primary cultures of embryonic cerebral cortical precursor cells. Int J Dev Neurosci 20 8 (2002) 593-606
52. Araki K.Y., Fujimura S., MacDonald M.E., and Bhide P.G. Characterization of mouse striatal precursor cell lines expressing functional dopamine receptors. Dev Neurosci 28 6 (2006) 518-527
53. Zhang L., Bai J., Undie A.S., Bergson C., and Lidow M.S. D1 dopamine receptor regulation of the levels of the cell-cycle-controlling proteins, cyclin D, P27 and Raf-1, in cerebral cortical precursor cells is mediated through cAMP-independent pathways. Cereb Cortex 15 1 (2005) 74-84
54. Reinoso B.S., Undie A.S., and Levitt P. Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res 43 (1996) 439-453
55. Stanwood G.D., and Levitt P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci 27 1 (2007) 152-157
56. Stanwood G.D., Parlaman J.P., and Levitt P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D(1) receptor mutant mice. J Comp Neurol 487 3 (2005) 270-282
57. Crandall J.E., McCarthy D.M., Araki K.Y., Sims J.R., Ren J.Q., and Bhide P.G. Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J Neurosci 27 14 (2007) 3813-3822
58. De Carlos J.A., López-Mascaraque L., and Valverde F. Dynamics of cell migration from the lateral ganglionic eminence in the rat. J Neurosci 16 (1996) 6146-6156
59. Wonders C.P., and Anderson S.A. The origin and specification of cortical interneurons. Nat Rev Neurosci 7 9 (2006) 687-696
60. Wang H.Y., Runyan S., Yadin E., and Friedman E. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J Pharmacol Exp Ther 273 (1995) 492-498
61. Unterwald E.M., Ivkovic S., Cuntapay M., Stroppolo A., Guinea B., and Ehrlich M.E. Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum. Brain Res Dev Brain Res 147 1-2 (2003) 67-75
62. Greengard P., Allen P.B., and Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23 3 (1999) 435-447
63. Zhen X., Torres C., Wang H.Y., and Friedman E. Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. J Neurosci 21 23 (2001) 9160-9167
64. Kubrusly R.C., Araki K.Y., and Bhide P.G. Cocaine modulates dopamine-adenosine interactions in the embryonic brain (2007), Society for Neuroscience, Washington, DC; San Diego, CA
65. Lidow M.S., and Song Z.M. Effect of cocaine on cell proliferation in the cerebral wall of monkey fetuses. Cereb Cortex 11 6 (2001) 545-551
66. Crandall J.E., Hackett H.E., Tobet S.A., Kosofsky B.E., and Bhide P.G. Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex 14 6 (2004) 665-675
67. Caviness Jr. V.S., Takahashi T., and Nowakowski R.S. Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. TINS 18 (1995) 379-383
68. Caviness Jr. V.S., Goto T., Tarui T., Takahashi T., Bhide P.G., and Nowakowski R.S. Cell output, cell cycle duration and neuronal specification: a model of integrated mechanisms of the neocortical proliferative process. Cereb Cortex 13 6 (2003) 592-598
69. Lidow M.S., and Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol 435 3 (2001) 263-275
70. Lidow M.S., Bozian D., and Song Z. Cocaine affects cerebral neocortical cytoarchitecture in primates only if administered during neocortical neuronogenesis. Brain Res Dev Brain Res 128 1 (2001) 45-52
71. Lidow M.S. Nonhuman primate model of the effect of prenatal cocaine exposure on cerebral cortical development. Ann NY Acad Sci 846 (1998) 182-193
72. He N., and Lidow M.S. Cerebral cortical abnormalities seen in a non-human primate model of prenatal cocaine exposure are not related to vasoconstriction. Neurotoxicology 25 3 (2004) 419-432
73. He F., Lidow I.A., and Lidow M.S. Inhalational model of cocaine exposure in mice: neuroteratological effects. Neurotoxicol Teratol 28 2 (2006) 181-197
74. Novikova S.I., He F., Bai J., and Lidow M.S. Neuropathology of the cerebral cortex observed in a range of animal models of prenatal cocaine exposure may reflect alterations in genes involved in the Wnt and cadherin systems. Synapse 56 2 (2005) 105-116
75. Morrow B.A., Elsworth J.D., and Roth R.H. Axo-axonic structures in the medial prefrontal cortex of the rat: reduction by prenatal exposure to cocaine. J Neurosci 23 12 (2003) 5227-5234
76. Ren J.Q., Malanga C.J., Tabit E., and Kosofsky B.E. Neuropathological consequences of prenatal cocaine exposure in the mouse. Int J Dev Neurosci 22 5-6 (2004) 309-320
77. Ben-Ari Y. Developing networks play a similar melody. Trends Neurosci 24 6 (2001) 353-360
78. Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3 9 (2002) 728-739
79. Ben-Ari Y., Khalilov I., Represa A., and Gozlan H. Interneurons set the tune of developing networks. Trends Neurosci 27 7 (2004) 422-427
80. Zachor D., Cherkes J.K., Fay C.T., and Ocrant I. Cocaine differentially inhibits neuronal differentiation and proliferation in vitro. J Clin Invest 93 3 (1994) 1179-1185
81. Zachor D.A., Moore J.F., Brezausek C., Theibert A., and Percy A.K. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors. Brain Res 869 1-2 (2000) 85-97
82. He N., Song Z., and Lidow M.S. Cocaine induces cell death within the primate fetal cerebral wall. Neuropathol Appl Neurobiol 25 6 (1999) 504-512
83. Riccio O, Potter G, Walzer C, Vallet P, Szabo G, Vutskits L, et al. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol Psychiatry 2008, doi:10.1038/mp.2008.89.
84. Yue Y., Widmer D.A.J., Halladay A.K., Cerretti D.P., Wagner G.C., Dreyer J.L., et al. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci 19 (1999) 2090-2101
85. Bainton R.J., Tsai L.T., Schwabe T., Desalvo M., Gaul U., and Heberlein U. Moody encodes two GPCRs that regulate cocaine behaviors and blood-brain barrier permeability in Drosophila. Cell 123 1 (2005) 145-156